ISSUE 82 I MAY 2019

Where is

my mind?

An experimental drug is fuelling hopes that a treatment for memory loss may be on the horizon

In association with

02/24/2024 02:26:36

04/25/2019 00:00:00

Go to article: Home | Where is my mind?Go to article: In this issue Go to article: Scandinavian Health Company Insight Go to article: Scandinavian Health Go to article: Contents Go to article: NSF Go to article: News Go to article: Daiichi Jitsugyo Go to article: The pharma industry briefing Go to article: International Cannabis and Cannabinoid Institute (ICCI) Company Insight Go to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Thumbs up for esketamine sheds light on potential for ketamine Go to article: Phoenix group Company Insight Go to article: Phoenix group Go to article: Charting the life and times of the EMA as it leaves London Go to article: Swiss WorldCargo Go to article: Capsugel Company Insight Go to article: Capsugel Go to article: Medical cannabis in the UK: how has the roll out gone so far? Go to article: EmboCaps Go to article: Barc Lab Go to article: Drug development: the researchers driving an open-science approach Go to article: Freudenberg Medical Go to article: Albypharma Go to article: The drugs fighting memory loss Go to article: Senn Chemicals Go to article: Pharma Hemp Go to article: RUNLABS: empowering life science through flexible working environments Go to article: Spirax Sarco Go to article: Spirax Sarco Company Insight Go to article: Events Go to article: Accurate Biometrics Company Insight Go to article: Accurate Biometrics Go to article: B&W Tek Go to article: Next issue Go to article: Pfanstiehl Go to article: Centaur Clinical | Company Insight Go to article: Centaur Clinical Go to article: Hapa Company Insight Go to article: Contract Pharmaceuticals Limited Canada